According to OPGEN INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:48 AM, company Chief Executive Officer, Schacht Oliver disclosed buying 10,000 shares at a cost of $1.50. At the time of this transaction (Nov 18), this trade was worth $14,960 in total. As […]
According to KIMBALL INTERNATIONAL INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:34 AM, company EVP & CFO, Wolfe Timothy J disclosed buying 5,000 shares at a cost of $10.99. At the time of this transaction (Nov 17), this trade was worth $54,950 in […]
According to Volcon, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:30 AM, company Director, James Adrian disclosed buying 14,400 shares at a cost of $16.11. At the time of this transaction (Nov 18), this trade was worth $231,951 in total. As of Nov […]
According to Inhibikase Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:13 AM, company President and CEO, Werner Milton H. disclosed buying 23,589 shares at a cost of $1.97. At the time of this transaction (Nov 17), this trade was worth $46,558 in […]
According to DraftKings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:02 AM, company Director, Levin Woodrow disclosed buying 7,000 shares at a cost of $36.81. At the time of this transaction (Nov 18), this trade was worth $257,670 in total. As of Nov […]
According to 9 METERS BIOPHARMA, INC.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 07:31 AM, company Chief Executive Officer, Temperato John disclosed buying 50,000 shares at a cost of $1.05. At the time of this transaction (Nov 18), this trade was worth $52,500 in […]
According to Axsome Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 07:30 AM, company Director, Saad Mark E disclosed buying 300 shares at a cost of $34.41. At the time of this transaction (Nov 17), this trade was worth $10,324 in total. As […]
According to Axsome Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 07:30 AM, company Director, Saad Mark E disclosed buying 3,000 shares at a cost of $34.53. At the time of this transaction (Nov 17), this trade was worth $103,597 in total. As […]
According to SeaWorld Entertainment, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 09:00 AM, company Chief Zoological Officer, Dold Christopher disclosed selling 26,462 shares at a cost of $63.00. At the time of this transaction (Nov 17), this trade was worth $1,667,106 in total. […]
According to Bank7 Corp.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 08:55 AM, company Exec. Vice President; CCO, Estes Jason E disclosed selling 580 shares at a cost of $25.29. At the time of this transaction (Nov 18), this trade was worth $14,668 in […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
